Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer

Circulating lncRNAs have been defined as a novel biomarker for non-small cell lung cancer (NSCLC), MALAT-1 was first identified lncRNA that was related to lung cancer metastasis. However, the relationship between exosomal lncRNAs and the diagnosis and prognosis of NSCLC was poorly understood. The ai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biochemical and biophysical research communications Jg. 490; H. 2; S. 406 - 414
Hauptverfasser:	Zhang, Rui, Xia, Yuhong, Wang, Zhixin, Zheng, Jie, Chen, Yafei, Li, Xiaoli, Wang, Yu, Ming, Huaikun
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 19.08.2017
Schlagworte:	60 APPLIED LIFE SCIENCES APOPTOSIS BIOLOGICAL MARKERS biomarkers blood serum Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology CELL CYCLE Cell Line, Tumor Cell Movement CELL PROLIFERATION COLONY FORMATION DIAGNOSIS Diagnostic marker Exosomes Exosomes - genetics Exosomes - pathology flow cytometry Gene Expression Regulation, Neoplastic HEALING Humans IN VITRO in vitro studies Lung - pathology lung neoplasms Lung Neoplasms - blood Lung Neoplasms - diagnosis Lung Neoplasms - genetics Lung Neoplasms - pathology LUNGS Lymphatic Metastasis - diagnosis Lymphatic Metastasis - genetics Lymphatic Metastasis - pathology MALAT-1 METASTASES metastasis Migration neoplasm cells NEOPLASMS non-coding RNA Non-small cell lung cancer PATIENTS Prognosis Proliferation RNA RNA, Long Noncoding - blood RNA, Long Noncoding - genetics small interfering RNA TUMOR CELLS Up-Regulation WOUNDS Diagnostic marker Proliferation Exosomes Migration Non-small cell lung cancer MALAT-1
ISSN:	0006-291X, 1090-2104, 1090-2104
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!